Jane Wasman

2018

In 2018, Jane Wasman earned a total compensation of $1.4M as President, International, General Counsel and Corporate Secretary at Acorda Therapeutics, a 15% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$863,543
Salary$570,900
Other$8,250
Total$1,442,693
59.86%

Wasman received $863.5K in non-equity incentive plan, accounting for 60% of the total pay in 2018.

Wasman also received $570.9K in salary and $8.3K in other compensation.

Rankings

In 2018, Jane Wasman's compensation ranked 7,351st out of 14,244 executives tracked by ExecPay. In other words, Wasman earned more than 48.4% of executives.

ClassificationRankingPercentile
All
7,351
out of 14,244
48th
Division
Manufacturing
2,852
out of 5,765
51st
Major group
Chemicals And Allied Products
1,074
out of 2,128
50th
Industry group
Drugs
908
out of 1,817
50th
Industry
Biological Products, Except Diagnostic Substances
168
out of 339
50th

Pay ratio

Jane Wasman's Pay$1,442,693
Median Employee's Pay$202,725
Pay Ratio

7

to 1

In 2018, the annual total compensation of Jane Wasman was $1,442,693.

The annual total compensation of the median employee at Acorda Therapeutics was $202,725.

The ratio of Jane Wasman's pay to the pay of median employee was therefore 7 to one.

Source: SEC filing on April 26, 2019.

Wasman's colleagues

We found five more compensation records of executives who worked with Jane Wasman at Acorda Therapeutics in 2018.

2018

Ron Cohen

Acorda Therapeutics

Chief Executive Officer

2018

Burkhard Blank

Acorda Therapeutics

Chief Medical Officer

2018

Andrew Hindman

Acorda Therapeutics

Chief Business Officer

2018

Lauren Sabella

Acorda Therapeutics

Chief Commercial Officer

2018

David Lawrence

Acorda Therapeutics

Chief, Business Operations and Principal Accounting Officer

News

You may also like